Tampa, FL, United States of America

Suraj Dixit

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of South Florida. Active years: 2017.

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suraj Dixit: Innovator in Respiratory Syncytial Virus Treatment

Introduction

Suraj Dixit is a notable inventor based in Tampa, Florida, recognized for his contributions to medical science, particularly in the treatment of respiratory syncytial virus (RSV) infections. His innovative work has the potential to impact the lives of many affected by this viral infection.

Latest Patents

Suraj Dixit holds a patent for "Compositions and methods for treating respiratory syncytial virus infection." This patent describes isolated polypeptides that are useful for treating RSV and outlines various methods and compositions aimed at combating this virus. He has 1 patent to his name, showcasing his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Suraj has worked with esteemed institutions such as the University of South Florida and the Moffitt Cancer Center Foundation for Research Development. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant research initiatives.

Collaborations

Suraj has collaborated with notable colleagues, including Julio Garay and Nancy Lucrecia Goicochea. These partnerships have enriched his research and expanded the scope of his innovative work.

Conclusion

Suraj Dixit is a dedicated inventor whose work in treating respiratory syncytial virus infection exemplifies the importance of innovation in healthcare. His contributions are paving the way for new treatments that could benefit countless individuals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…